Jimmy Wei

Dr. Wei, President of Chime Biologics, is a healthcare and life sciences executive with over two decades of global experience. Prior to joining Chime Biologics, Dr. Wei has led the incubation and investments activities into multiple well-known biotech companies, including Zai Lab, I-Mab, XW Labs, CMAB and JHL Biotech.

Dr. Wei was a founding partner of Pivotal Capital and I-Bridge Capital, and a partner of KPCB China Fund. Before joining KPCB, Dr. Wei was Senior Vice President and Head of Business Development at Hutchison Medipharma, where he was responsible for establishing global partnerships with several multinational pharmaceutical companies, including AstraZeneca, Johnson & Johnson, Lilly etc.

Dr. Wei graduated from North Carolina State University with PhD in biochemistry. He also holds an MBA with honors from the Darden Business School, University of Virginia, and a Bachelor’s degree in Biology from Wuhan University.